Skip to Main Content
 

Tri-Institutional Therapeutics Discovery Institute
 
The Tri-Institutional Discovery Institute (Tri-I TDI) is a partnership between The Rockefeller University, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. Focusing on early-stage drug discovery, the Tri-I TDI provides expertise to researchers in medicinal chemistry and compound screening, and conducts "proof-of-concept" studies. The Institute also provides opportunities for training students and post-doctoral fellows, and enabling faculty to be involved in the drug discovery procees in order to support translational research.
 
More...
 
 
 
We value your comments and rely on your feedback to improve our services.